PMID: 3768848Nov 1, 1986Paper

Congenital acute nonlymphoblastic leukemia with translocation (9;18)

Cancer Genetics and Cytogenetics
G GaleJ Y Chu

Abstract

Chromosome analysis is becoming an increasingly important tool in the diagnosis and treatment of childhood malignancies. This report illustrates a new translocation t(9;18) in a neonate with congenital acute nonlymphocytic leukemia, which predicted a bone marrow relapse in a normal appearing bone marrow.

References

Jun 1, 1983·Cancer Genetics and Cytogenetics·R AbeA A Sandberg
Jan 1, 1983·Cytogenetics and Cell Genetics·F Mitelman

❮ Previous
Next ❯

Citations

Oct 1, 1992·Cancer Genetics and Cytogenetics·R Sansone, D Negri
May 25, 2002·British Journal of Haematology·Dorine BrestersGertjan J L Kaspers
Jan 1, 1989·Leukemia Research·D V Razis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.